Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management
X-linked Traits
Cholesterol: Significance and Regulation
Atherosclerosis I: Introduction
Chronic Pancreatitis II: Collaborative Care
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 15, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Seham Abdallah Elazab1, Shrouk F Mohamed2, Abdelrahman Mohamed Hatata3
1Faculty of Medicine, Al Azhar University, Cairo, Egypt.
Heterozygous familial hypercholesterolemia (HeFH) is often underdiagnosed, especially in rural and low-income populations. Early diagnosis and treatment, including lipid-lowering therapy, are crucial for preventing cardiovascular disease in HeFH patients.
Area of Science:
Background: